(PRWEB) February 22, 2013
The US Drug Watchdog says, "We now fear a young healthy woman would not think of birth control pills as being the possible culprit in completely out of the blue heart attack, stroke, a pulmonary embolism, or severe blood clotting. However, when it comes to the birth control pills called Yaz, Yasmin, or the generic version called Ocella that is exactly what we are saying, and we need help in getting the word out. We could be talking about something that happened five years ago, or more, because of this we need family members, or friends to help us get the word out. According to the September 17th 2009 edition of the New York Times, "The FDA released a warning letter sent in September to Bayer Pharmaceuticals over Yaz & Yasmin. The FDA letter was very critical of the drug maker for failing to highlight the risk factors associated with these birth control pills. The US Drug Watchdog says, "If a user of the birth control pills called Yaz, Yasmin, or the generic version Ocella has had a pulmonary embolism, a heart attack, stroke, blood clotting, or other serious medical issues, regardless of how long ago, they should contact the Johnson Law Group immediately at 1-800-996-9900." http://www.johnsonlawgroup.com/
Possible Side Effects Yaz/Yasmin Birth Control Pills
The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. We are attempting to change this very sad fact with aggressive initiatives focused on increasing public awareness, and suggesting possible help for victims. With respect to the birth control pills called Yaz, Yasmin, or the generic version Ocella the severe medical side effect could have occurred five years ago in California, Florida, in New York, or any other US state. Our big worry now is we may run out of time to get these victims identified." http://USDrugWatchdog.Com
MDL No. 2100 (3:09-md-02100-DRH-PMF)
Read the full story at http://www.prweb.com/releases/2013/2/prweb10431559.htm.
Copyright©2012 Vocus, Inc.
All rights reserved